Ohio Public Employees Retirement System (OPERS)’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
PA
Ohio Public Employees Retirement System (OPERS)'s CORT Position: Q2 2026 in Review
Ohio Public Employees Retirement System (OPERS) reduced its Corcept Therapeutics (CORT) stake by 0.84% in Q2 2026, selling an estimated $14.2K and leaving 27,596 shares worth $2.4M. The position accounts for 0.01% of the portfolio, ranked #998.
Ohio Public Employees Retirement System (OPERS) first reported a position in CORT in Q3 2018 and has held it in 22 quarters since. The position peaked at $2.65M in Q3 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) held 27,596 shares of Corcept Therapeutics worth $2.4M as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) sold 235 Corcept Therapeutics shares in Q2 2026, an estimated $14.2K.
- Corcept Therapeutics made up 0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #998 holding.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Corcept Therapeutics in Q3 2018 and has held it in 22 quarters since.
- Ohio Public Employees Retirement System (OPERS)'s Corcept Therapeutics position peaked at $2.65M in Q3 2025.
- 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.